Abiopharma

🔍 Lambert Danielle (Director)

Company: Horizon Quantum Holdings Ltd. (HQ)

Report Date: 2026-03-19

Detailed Transactions and Holdings:

• Acquired 84,602 shares of Class A Ordinary Shares at $11.82 per share (Direct)
  Date: 2026-03-19 | Code: P | equity_swap_involved: 0 | shares_owned_after: 84,602.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2, F2

Footnotes:

• F1: On March 6, 2026, dMY Squared Technology Group, Inc. ("dMY"), the Company, and Horizon Quantum Computing Pte. Ltd. entered into a subscription agreement with Penchant Family Holdings LLC, whereby the Company, upon the closing of the Company's business combination with dMY, would issue 84,602 shares of the Company's Class A ordinary shares, with no par value (the "Class A Ordinary Shares") to Penchant Family Holdings LLC at a price per share of $11.82, for an aggregate purchase price of approximately $1,000,000. The closing of the Company's business combination occurred on March 19, 2026, and the 84,602 Class A Ordinary Shares of the Company were sold to Penchant Family Holdings LLC on that date.
• F2: Penchant Family Holdings LLC is controlled by Penchant Holdings, Inc., its Managing Member, of which Danielle Lambert serves as its President.